Procalcitonin as a predictor of renal scarring in infants and young children

Silvia Bressan, Barbara Andreola, Pietro Zucchetta, Giovanni Montini, Marta Burei, Giorgio Perilongo, Liviana Da Dalt

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The aim of this study was to evaluate the usefulness of procalcitonin (PCT) as a marker of renal scars in infants and young children with a first episode of acute pyelonephritis. Children aged 7 days to 36 months admitted for first febrile urinary tract infection (UTI) to a pediatric emergency department were prospectively enrolled. The PCT concentration was determined at admission. Acute 99mTc-dimercaptosuccinic acid (DMSA) scintigraphy was performed within 7 days of admission and repeated 12 months later when abnormal findings were obtained on the first scan. Of the 72 children enrolled in the study, 52 showed signs of acute pyelonephritis (APN) on the first DMSA scan. A follow-up scintigraphy at the 12-month follow-up performed on 41 patients revealed that 14 (34%) patients had developed renal scars; these patients also presented significantly higher PCT values than those without permanent renal lesions [2.3 (interquartile range 1-11.6) vs. 0.5 (0.2-1.4) ng/mL; p = 0.007]. A comparison of the PCT concentration in patients with febrile UTI without renal involvement, with APN without scar development and with APN with subsequent renal scarring revealed a significant increasing trend (p = 0.006, Kruskal-Wallis test). The area under the ROC curve for scar prediction was 0.74 (95% confidence interval 0.61-0.85), with an optimum statistical cut-off value of 1 ng/mL (sensitivity 78.6%; specificity 63.8%). Based on these results, we suggest that serum PCT concentration at admission is a useful predictive tool of renal scarring in infants and young children with acute pyelonephritis.

Original languageEnglish
Pages (from-to)1199-1204
Number of pages6
JournalPediatric Nephrology
Volume24
Issue number6
DOIs
Publication statusPublished - 2009

Fingerprint

Calcitonin
Pyelonephritis
Cicatrix
Kidney
Urinary Tract Infections
Radionuclide Imaging
Fever
Technetium Tc 99m Dimercaptosuccinic Acid
Succimer
ROC Curve
Area Under Curve
Hospital Emergency Service
Confidence Intervals
Pediatrics
Serum

Keywords

  • Children
  • DMSA scan
  • Procalcitonin
  • Renal scar
  • Urinary tract infection

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

Bressan, S., Andreola, B., Zucchetta, P., Montini, G., Burei, M., Perilongo, G., & Da Dalt, L. (2009). Procalcitonin as a predictor of renal scarring in infants and young children. Pediatric Nephrology, 24(6), 1199-1204. https://doi.org/10.1007/s00467-009-1125-x

Procalcitonin as a predictor of renal scarring in infants and young children. / Bressan, Silvia; Andreola, Barbara; Zucchetta, Pietro; Montini, Giovanni; Burei, Marta; Perilongo, Giorgio; Da Dalt, Liviana.

In: Pediatric Nephrology, Vol. 24, No. 6, 2009, p. 1199-1204.

Research output: Contribution to journalArticle

Bressan, S, Andreola, B, Zucchetta, P, Montini, G, Burei, M, Perilongo, G & Da Dalt, L 2009, 'Procalcitonin as a predictor of renal scarring in infants and young children', Pediatric Nephrology, vol. 24, no. 6, pp. 1199-1204. https://doi.org/10.1007/s00467-009-1125-x
Bressan, Silvia ; Andreola, Barbara ; Zucchetta, Pietro ; Montini, Giovanni ; Burei, Marta ; Perilongo, Giorgio ; Da Dalt, Liviana. / Procalcitonin as a predictor of renal scarring in infants and young children. In: Pediatric Nephrology. 2009 ; Vol. 24, No. 6. pp. 1199-1204.
@article{09b9eed0187149e79ff41ebf5c7bec23,
title = "Procalcitonin as a predictor of renal scarring in infants and young children",
abstract = "The aim of this study was to evaluate the usefulness of procalcitonin (PCT) as a marker of renal scars in infants and young children with a first episode of acute pyelonephritis. Children aged 7 days to 36 months admitted for first febrile urinary tract infection (UTI) to a pediatric emergency department were prospectively enrolled. The PCT concentration was determined at admission. Acute 99mTc-dimercaptosuccinic acid (DMSA) scintigraphy was performed within 7 days of admission and repeated 12 months later when abnormal findings were obtained on the first scan. Of the 72 children enrolled in the study, 52 showed signs of acute pyelonephritis (APN) on the first DMSA scan. A follow-up scintigraphy at the 12-month follow-up performed on 41 patients revealed that 14 (34{\%}) patients had developed renal scars; these patients also presented significantly higher PCT values than those without permanent renal lesions [2.3 (interquartile range 1-11.6) vs. 0.5 (0.2-1.4) ng/mL; p = 0.007]. A comparison of the PCT concentration in patients with febrile UTI without renal involvement, with APN without scar development and with APN with subsequent renal scarring revealed a significant increasing trend (p = 0.006, Kruskal-Wallis test). The area under the ROC curve for scar prediction was 0.74 (95{\%} confidence interval 0.61-0.85), with an optimum statistical cut-off value of 1 ng/mL (sensitivity 78.6{\%}; specificity 63.8{\%}). Based on these results, we suggest that serum PCT concentration at admission is a useful predictive tool of renal scarring in infants and young children with acute pyelonephritis.",
keywords = "Children, DMSA scan, Procalcitonin, Renal scar, Urinary tract infection",
author = "Silvia Bressan and Barbara Andreola and Pietro Zucchetta and Giovanni Montini and Marta Burei and Giorgio Perilongo and {Da Dalt}, Liviana",
year = "2009",
doi = "10.1007/s00467-009-1125-x",
language = "English",
volume = "24",
pages = "1199--1204",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Procalcitonin as a predictor of renal scarring in infants and young children

AU - Bressan, Silvia

AU - Andreola, Barbara

AU - Zucchetta, Pietro

AU - Montini, Giovanni

AU - Burei, Marta

AU - Perilongo, Giorgio

AU - Da Dalt, Liviana

PY - 2009

Y1 - 2009

N2 - The aim of this study was to evaluate the usefulness of procalcitonin (PCT) as a marker of renal scars in infants and young children with a first episode of acute pyelonephritis. Children aged 7 days to 36 months admitted for first febrile urinary tract infection (UTI) to a pediatric emergency department were prospectively enrolled. The PCT concentration was determined at admission. Acute 99mTc-dimercaptosuccinic acid (DMSA) scintigraphy was performed within 7 days of admission and repeated 12 months later when abnormal findings were obtained on the first scan. Of the 72 children enrolled in the study, 52 showed signs of acute pyelonephritis (APN) on the first DMSA scan. A follow-up scintigraphy at the 12-month follow-up performed on 41 patients revealed that 14 (34%) patients had developed renal scars; these patients also presented significantly higher PCT values than those without permanent renal lesions [2.3 (interquartile range 1-11.6) vs. 0.5 (0.2-1.4) ng/mL; p = 0.007]. A comparison of the PCT concentration in patients with febrile UTI without renal involvement, with APN without scar development and with APN with subsequent renal scarring revealed a significant increasing trend (p = 0.006, Kruskal-Wallis test). The area under the ROC curve for scar prediction was 0.74 (95% confidence interval 0.61-0.85), with an optimum statistical cut-off value of 1 ng/mL (sensitivity 78.6%; specificity 63.8%). Based on these results, we suggest that serum PCT concentration at admission is a useful predictive tool of renal scarring in infants and young children with acute pyelonephritis.

AB - The aim of this study was to evaluate the usefulness of procalcitonin (PCT) as a marker of renal scars in infants and young children with a first episode of acute pyelonephritis. Children aged 7 days to 36 months admitted for first febrile urinary tract infection (UTI) to a pediatric emergency department were prospectively enrolled. The PCT concentration was determined at admission. Acute 99mTc-dimercaptosuccinic acid (DMSA) scintigraphy was performed within 7 days of admission and repeated 12 months later when abnormal findings were obtained on the first scan. Of the 72 children enrolled in the study, 52 showed signs of acute pyelonephritis (APN) on the first DMSA scan. A follow-up scintigraphy at the 12-month follow-up performed on 41 patients revealed that 14 (34%) patients had developed renal scars; these patients also presented significantly higher PCT values than those without permanent renal lesions [2.3 (interquartile range 1-11.6) vs. 0.5 (0.2-1.4) ng/mL; p = 0.007]. A comparison of the PCT concentration in patients with febrile UTI without renal involvement, with APN without scar development and with APN with subsequent renal scarring revealed a significant increasing trend (p = 0.006, Kruskal-Wallis test). The area under the ROC curve for scar prediction was 0.74 (95% confidence interval 0.61-0.85), with an optimum statistical cut-off value of 1 ng/mL (sensitivity 78.6%; specificity 63.8%). Based on these results, we suggest that serum PCT concentration at admission is a useful predictive tool of renal scarring in infants and young children with acute pyelonephritis.

KW - Children

KW - DMSA scan

KW - Procalcitonin

KW - Renal scar

KW - Urinary tract infection

UR - http://www.scopus.com/inward/record.url?scp=67650333149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650333149&partnerID=8YFLogxK

U2 - 10.1007/s00467-009-1125-x

DO - 10.1007/s00467-009-1125-x

M3 - Article

C2 - 19205751

AN - SCOPUS:67650333149

VL - 24

SP - 1199

EP - 1204

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 6

ER -